Update on melanoma: The present position

British Journal of Oral and Maxillofacial Surgery

Volumn 48, Issue 8, 2010, Pages 575-578

  Godden, Daryl ^a   Brennan, Peter A ^b   Milne, James ^a  

^a GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^b QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

Head and neck; Melanoma; Review

Indexed keywords

ALPHA INTERFERON; BEVACIZUMAB; INTERFERON;

ARTICLE; AWARENESS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER PREVENTION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG MEGADOSE; HIGH RISK PATIENT; HUMAN; MELANOMA; NON PROFIT ORGANIZATION; SENTINEL LYMPH NODE BIOPSY; SKIN GRAFT; SUN EXPOSURE; TUMOR VOLUME; ULTRAVIOLET RADIATION;

HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MELANOMA; NEOADJUVANT THERAPY; PATIENT CARE TEAM; SKIN NEOPLASMS; SUNLIGHT; ULTRAVIOLET RAYS;

EID: 78649303302     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjoms.2009.10.029     Document Type: Article

References (21)

1. UK Incidence Statistics for skin cancer. http://info.cancerresearchuk. org/cancerstats/types/skin/incidence/ ; 2009 [accessed 07.07.09].
2. A. Fourtanier, D. Moyal, and S. Seité Sunscreens containing the broad-spectrum UVA absorber, Mexoryl SX, prevent the cutaneous detrimental effects of UV exposure: a review of clinical study results Photodermatol Photoimmunol Photomed 24 2008 164 174
3. D.D. Moyal, and A.M. Fourtanier Broad-spectrum sunscreens provide better protection from solar ultraviolet-simulated radiation and natural sunlight-induced immunosuppression in human beings J Am Acad Dermatol 58 5 Suppl. 2 2008 S149 S154
4. D.M. Lipsker, G. Hedelin, E. Heid, E.M. Grosshans, and B.J. Cribier Striking increase of thin melanomas contrasts with stable incidence of thick melanomas Arch Dermatol 135 1999 1451 1456
5. R.M. MacKie, C.A. Bray, D.J. Hole, A. Morris, M. Nicolson, and A. Evans Incidence of and survival from malignant melanoma in Scotland: an epidemiological study Lancet 360 2002 587 591
6. UK Skin Cancer mortality statistics. http://info.cancerresearchuk.org/ cancerstats/types/skin/mortality/ ; 2009 [accessed 02.0709].
7. B.L. Diffey A quantitative estimate of melanoma mortality from ultraviolet A sunbed use in the U.K. Br J Dermatol 149 2003 578 581
8. P. Autier, J.F. Doré, S. Négrier, D. Lienard, R. Panizzon, and F.J. Lejeune Sunscreen use and duration of sun exposure: a double-blind, randomized trial J Natl Cancer Inst 91 1999 1304 1309
9. J. Westerdahl, C. Ingvar, A. Mâsbäck, and H. Olsson Sunscreen use and malignant melanoma Int J Cancer 87 2000 145 150
10. J. Espinosa Arranz, J.J. Sanchez Hernandez, P. Bravo Fernandez, M. Gonzalez-Baron, P. Zamora Aunon, and E. Espinosa Arranz Cutaneous malignant melanoma and sun exposure in Spain Melanoma Res 9 1999 199 205
11. S. Gandini, F. Sera, M.S. Cattaruzza, P. Pasquini, R. Zanetti, and C. Masini Meta-analysis of risk factors for cutaneous melanoma. III. Family history, actinic damage and phenotypic factors Eur J Cancer 41 2005 2040 2059
12. B.L. Diffey The future incidence of cutaneous melanoma within the UK Br J Dermatol 151 2004 868 872
13. Roberts DL, Anstey AV, Barlow RJ, Cox NH, Newton Bishop JA, Corrie PG, et al. British Association of Dermatologists Melanoma Study Group. UK guidelines for the management of cutaneous melanoma. Br J Dermatol 2002;146:7-17. http://www.ncbi.nlm.nih.gov/pubmed/11841361?ordinalpos=3&itool= EntrezSystem2.PEntrez.Pubmed.Pubmed-ResultsPanel.Pubmed-DefaultReportPanel. Pubmed-RVDocSum.
14. Improving outcomes for people with skin tumours including melanoma. http://www.nice.org.uk/csgstim ; Feb 2006 [accessed 12.06.09].
15. Concise guidelines for good practice. In: The prevention, diagnosis and referral and management of melanoma of the skin. London: Royal College of Physicians. http://www.bad.org.uk/Portals/-Bad/Guidelines/Clinical%20Guidelines/ RCP%20Melanoma%20Guidelines%202007.pdf ; 2007 [accessed 12.06.09].
16. U. Veronesi, and N. Cascinelli Narrow excision (1cm margin). A safe procedure for thin cutaneous melanoma Arch Surg 126 1991 438 441
17. C.M. Balch, S.J. Soong, T. Smith, M.I. Ross, M.M. Urist, and C.P. Karakousis Investigators from the Intergroup Melanoma Surgical Trial. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas Ann Surg Oncol 8 2001 101 108
18. J.M. Thomas, J. Newton-Bishop, R. A'Hern, G. Coombes, M. Timmons, and J. Evans United Kingdom Melanoma Study Group; British Association of Plastic Surgeons; Scottish Cancer Therapy Network. Excision margins in high-risk malignant melanoma N Engl J Med 350 2004 757 766
19. D.L. Morton, J.F. Thompson, A.J. Cochran MSLT Group Sentinel-node biopsy or nodal observation in melanoma N Engl J Med 355 2006 1307 1317 Erratum in: N Engl J Med 2006;355;18:1944.
20. J. Glaspy, A. Ribas, and B. Chmielowski Interferon alfa in the postsurgical management of high-risk melanoma: is it worth it? J Clin Oncol 27 2009 2896 2897
21. J.M. Kirkwood, J.G. Ibrahim, J.A. Sosman, V.K. Sondak, S.S. Agarwala, and M.S. Ernstoff High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801 J Clin Oncol 19 2001 2370 2380